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Objectives: To analyse the histopathological features of in situ vein bypass tenoses. 
Materials and Methods: Nineteen specimens of primary (n = 16) or recurrent (n = 3) vein graft stenoses obtained from 
17 patients during surgical revision were prepared for light microscopy and immunohistochemical investigation. The 
median time interval from bypass surgery to stenosis excision was 5 months (range 2-52 months). Twenty-seven 
saphenous vein segments obtained from patients undergoing primary bypass surgery served as controls. 
Results: Graft stenoses were charaeterised by moderate to severe intimal hyperplasia composed of actin positive but 
desmin negative cells, interspersed with areas of fi'brosis. A single layer of factor VIII positive endothelial cells were 
identified on the luminal surface. The media, separated from the intima by a poorly defined elastic lamina, usually 
appeared normal or mildly hyperplastic and consisted of smooth muscle cells, which stained positive for actin as well as 
for desmin. The adventitia was composed of loose connective tissue in which lymphocytes, plasma cells and giant cells 
were occasionally seen. Atheromatous material was absent from intragraft lesions, but was observed in one specimen, 
which was harvested from a proximal anastomotic lesion. The majority of pre-bypass vein segments showed evidence of 
intimal thickening whereas medial hyperplasia was less common. 
Conclusions: In situ vein bypass tenoses mainly consisted of intimal hyperplasia nd varying degrees of fibrosis. Similar 
but less pronounced morphological changes were found in pre bypass vein segments. The nature of the actin positive but 
desmin and factor VIII negative intima cells is uncertain, and further studies are needed to characterise this cell type. 
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Introduction 
Infrainguinal vein bypass surgery has become an es- 
tablished procedure for lower extremity re- 
vascularisation, providing long-term patency rates 
ranging from 60-90%. 1-3 Early reconstruction failures 
occurring within the first postoperative month have 
been attributed to inadequate patient selection or tech- 
nical problems related to the operation. Late failures 
occuring more than 1-2 years after surgery mainly 
result from progression of atherosclerosis in the in- 
and outflow arteries as well as in the graft. Failures 
in the intermediate p riod account for the majority of 
all failures and result from graft-related stenoses. 4-~° 
The pathogenesis of vein graft stenoses has been ex- 
tensively studied in vitro and in animal models. 11-1s 
The initiating event is assumed to be intraoperative 
injury of the saphenous vein, which in combination 
with humoral factors and endothelial dysfunction 
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leads to an accelerated healing response resulting in 
progressive intimal thickening and consequently u- 
minal narrowing. 1°'~1'~5'~6 A detailed immuno- 
histochemical nalysis of the cellular components of 
vein bypass stenoses in humans, however, has not 
previously been carried out. With the aim of gaining 
further insight into the pathogenesis of vein graft 
failure, we analysed the composition of surgically 
corrected in situ vein bypass stenoses. 
Materials and Methods 
Nineteen tissue specimens from 17 patients were har- 
vested during surgical revision of strictured in situ 
vein grafts at the Department of Vascular Surgery, 
Rigshospitalet, Copenhagen between March 1992 and 
July 1995. The median age of the 12 males and five 
females was 73 years (range 39-82 years). Seven (41%) 
patients had diabetes, four (24%) were hypertensive 
and 14 (82%) were current or previous mokers. Sten- 
osis characteristics were determined angiographically. 
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Four (21%) stenoses were located at the proximal 
anastomosis, 10 (53%) in the body of the graft and five 
(26%) at the distal anastomosis. The luminal diameter 
reduction was 50-79% in eight (42%) and ___ 80% in 11 
(58%) cases. Stenosis length was <1 cm in five (26%) 
cases, 1.0-4.9 cm in 10 (53%) cases and >5 cm in four 
(21%) cases. 
Sixteen specimens were retrieved from primary le- 
sions, whereas three were from recurrent or residual 
lesions after previous percutaneous transluminal an- 
gioplasty (n = 2) or surgical revision (n = 1). The median 
time from the bypass operation to re-intervention was 
5 months (range 2-52 months). Fourteen (74%) lesions 
were excised in total and a biopsy was obtained in 
the other five (26%) cases. All biopsies were taken at 
right angles to the vessel, included the entire vessel 
wall and typically measured 2 x 3 x 6 ram. Pre-bypass 
vein segments obtained from the distal end of the 
saphenous vein in 27 patients (19 males and eight 
females, median age 68 years (range 40-85 years)) 
undergoing primary vein bypass surgery served as 
controls. The specimens were fixed in formalin and 
embedded inparaffin. Sections were cut from the most 
severely stenosed part of the specimens and stained 
with hematoxylin-eosin a d Verhoeffs taining method 
for elastin. Immunohistochemical staining for actin, 
desmin, vimentin and factor VIII was used to identify 
the cellular components. The histological changes were 
semi-quantified in four grades: grade I represented no 
or minimal hyperplasia, grade II mild hyperplasia, 
grade III moderate hyperplasia nd grade IV severe 
hyperplasia, as previously described by Milroy et al. 17 
Immunohistochemical techniques 
The antibodies used were: Monoclonal mouse anti- 
human m-smooth muscle actin (DAKOpatts M 0851, 
diluted 1:100), monoclonal mouse anti-swine desmin 
(DAKOpatts M 724, diluted 1:100), monoclonal mouse 
anti-swine vimentin (DAKOpatts M 725, diluted 
1:400) and rabbit anti-human von Willebrand factor 
(factor VIII, DAKOpatts A 082, diluted 1:200). 
For the monoclonal anti-bodies an avidin-biotin 
three stage method was used (DAKOpatts K 0355). 
For the polyclonal antibody a three stage peroxidase- 
antiperoxidase technique was used (DAKOpatts Z 
0113). As chromogen, 3-amino-9-ethylcarbazole (AEC) 
was used. 
The antibody against actin reacts with the c~-smooth 
muscle isoform of actin. The antibody does not react 
with actin from fibroblasts, striated muscle or myo- 
cardium. The antibody reacts with smooth muscle cells 
of vessels and different parenchymes. The antibody 
against desmin reacts with 53 kD intermediate filament 
protein desmin in muscle cells. The antibody does not 
appear to recognise other filament proteins. In normal 
tissue it reacts with striated and smooth muscle cells. 
The labelling is confined to the Z bands in skeletal 
and cardiac muscle. The antibody against vimentin 
reacts with vimentin, the 57 kD intermediate filament 
protein present in cells of mesenchymal origin. Cells 
positive to the antibody include lymphoid cells, endo- 
thelial cells, fibroblasts and smooth muscle. Some cells 
co-express another intermediate filament protein be- 
sides vimentin. An example of this is vascular smooth 
muscle cells, which co-express desmin and vimentin. 
The antibody against factor VIII was raised against von 
Willebrand factor in human plasma, and reacts with 
endothelial ceils in the vessels. 
Statistics 
The frequency of histological changes in vein graft 
stenoses and in pre-bypass vein segments was com- 
pared by Fisher's exact test. 
Results 
Primary intermediate (1-24 months postoperative) 
stenoses (n = 14) 
In two of the vein biopsies the layers were poorly 
defined and grading of the histological changes was 
not possible. The remaining 12 specimens were char- 
acterised by moderate (n =4) to severe (n =8) intimal 
hyperplasia (Table 1) (Fig. 1). In all instances a single 
layer of factor VIII positive endothelial cells lined the 
luminal surface (Fig. 2b) and several ayers of actin 
positive but desmin negative cells were located be- 
neath the endothelium (Fig. 2c and 2d). Variable de- 
grees of fibrotic changes were found in the thickened 
intima. The border between intima and media was 
only vaguely defined, because the inner elastic laminae 
were split and partly disrupted. Thickening of the 
medial muscle layers was common, but generally less 
pronounced than the intimal thickening (Table 1). The 
media was composed of smooth muscle cells, which 
were positive for both actin and desmin (Fig. 2c and 
2d). The adventitia consisted of loose connective tissue 
in which lymphocytes, plasma cells or giant cells oc- 
casionally were present. Scattered vimentin positive 
fibroblasts were found in all layers. No lipid, haem- 
orrhage, thrombus or calcification was identified. 
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Table 1. Histological changes in 12 (#) infrainguinal vein bypass stenoses revised between 1 and 24 months postoperatively. 
Intima Media 
Inner longitudinal Circular Outer longitudinal 
muscle layer muscle layer muscle layer 
No or minimal hyperplasia (Grade I) 0 
Mild hyperplasia (Grade II) 0 
Moderate hyperplasia (Grade III) 4 
Severe hyperplasia (Grade IV) 8 
p-value 0.02 
3 6 9 
9 4 3 
0 2 0 
0 0 0 
0.006 0.2 0.9 
p-values indicate results of Fisher's exact test when comparing the frequency of grade II-IV changes in vein graft stenoses and in pre- 
bypass vein segments: #=in two specimens with poorly defined layers the histological changes could not be classified. 
Fig. 1. Stenosed vein grafts. (a) Vein graft stenosis (Verhoeff stain, magnification x 12); (b) severe hyperplasia nd high grade stenosis 
(Verhoeff stain, magnification x 12). 
Primary late (>24 months postoperative) stenoses (n = 2) 
A specimen obtained from a stenosis located at the 
proximal anastomosis 33 months postoperatively was 
composed of rather acellular connective tissue in ad- 
dition to atheromatous material and calcification. The 
cells were predominantly actin positive, a few stained 
for vimentin, but there was no reaction in the d smin 
staining. An intragraft stenosis retrieved 52 months 
after surgery consisted of intimal hyperplasia which 
was markedly fibrotic. 
Recurrent~residual stenoses (n = 3) 
The recurrent lesions were characterised by intimal 
hyperplasia consisting of actin positive cells and were 
lined by a layer of factor VIII positive ndothelial cells 
on the luminal surface. The media was composed 
of actin and desmin positive smooth muscle cells. 
Lymphocytes and giant cells were present in adventitia 
in two patients. A fresh thrombus was noted in one 
patient, which had been subjected to unsuccessful 
balloon angioplasty 4 days prior to the stenosis ex- 
cision. 
Pre-bypass vein segments serving as controls (n = 27) 
In 16 (59%) patients the pre-bypass vein segments 
showed evidence of mild (n = 11), moderate (n =3) or 
severe (n = 2) intimal thickening (Fig. 3), consisting of 
actin positive but desmin negative cells (Table 2). The 
luminal surface was lined by a single layer of factor 
VIII positive endothelial cells and the outermost limit 
of intima was marked by a poorly defined elastic 
lamina. One specimen contained atheromatous ma- 
terial and calcification. The three muscular layers in 
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Fig. 2. Vein graft stenosis with severe intimal hyperplasia, magnification x30. (a) Verhoeff stain (i=intima, re=media); (b) immuno- 
histochemical staining for factor VIII (arrow indicates endothelial cells); (c) immunohistochemical staining for actin; (d) immuno- 
histochemical staining for desmin. 
the media appeared normal or mildly thickened in the 
majority of cases (Table 2). The medial cells stained 
positive for actin as well as for desmin. The adventitia 
was composed of loose connective tissue in which 
disrupted elastic laminae were identified. 
Discussion 
Early studies addressing vein bypass histopathology 
were based on grafts excised following thrombosis 
or at autopsy, usually several months after bypass 
surgery. 7"1s These studies have provided valuable in- 
sight into the morphological response to arterialisation 
of the saphenous vein. With the introduction ofroutine 
bypass urveillance, analysis of focal stenoses obtained 
during elective bypass revision has also become pos- 
sible. However, as the number of surgical revisions is 
limited, these latter studies only comprise a total of 
27 specimens, and furthermore immunohistochemistry 
has rarely been used 19-21 (Table 3). The present study 
confirmed previous observations that vein graft sten- 
oses predominantly consist of a rather cellular intimal 
or subintimal hyperplasia. A detailed immuno- 
histochemical nalysis revealed that the medial cells, 
which contained both contractile actin f laments and 
intermediate desmin filaments, "were true smooth 
muscle cells. On the other hand, the unexpected finding 
that the intima cells contained actin but not desmin 
filaments questions the nature of these cells. The ab- 
sence of factor VIII activity suggests that they do not 
originate from endothelial cells, whereas the absence 
of desmin suggests that if they originate from smooth 
muscle cells they must have undergone structural 
alteration. Further studies, preferably using a com- 
bination of immunohistochemistry and electron micro- 
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Fig. 3. Pre-bypass vein segments. (a) Normal vein (Verhoeff stain, magnification x 30); (b) vein with intimal hyperplasia (Verhoeff stain, 
magmfication x 30). 
Table 2. Histological changes in 27 control vein segments obtained from patients undergoing primary infrainguinal vein bypass 
surgery. 
Intima Media 
Inner longitudinal Circular Outer longitudinal 
muscle layer muscle layer muscle layer 
No or minimal hyperplasia (Grade I) 
Mild hyperplasia (Grade II) 
Moderate hyperplasia (Grade III) 
Severe hyperplasia (Grade IV) 
11 21 17 22 
11 5 8 5 
3 0 1 0 
2 1 1 0 
Table 3. Reported studies on histopathology of failing infrainguinal vein bypasses. 
Study Number Time interval from surgery Histological Main findings 
of grafts to tissue harvest methods 
months (range) 
Szilagyi et al. (1973) 21 * 20 (6-96) LM Atherosclerosis (n=8) 
Fibrosis (n - 7) 
IH (n =4) 
"Normal" grafts (n=2) 
IH (n = 6) 
"Normal" grafts (n -5)  
Sottiurai et aL 11 * (11-43) LM + EM 
(1983) 
Matin et aL (1993) 8 § 6 (3-13) LM 
Sayers et al. (1993) 4 § 24 (7-60) LM 
Anti-actin 
Marin et aL (1993) 15 § Not reported LM 






Cellular IH (n = 4) 
Mixed fibrous and cellular IH (n = 11) 
Mixed fibrous and cellular IH (n = 18) 
Atherosclerosis (n= 1) 
LM = light microscopy; EM = electron microscopy; anti-actin =immunohistochemical st ining for actin; anti-desmin = immunohistochemical 
staining for desmin; anti-vimentin-immunohistochemical staining for vimentin; IH = intimal hyperplasia; *=specimens harvested from 
thrombosed grafts or at autopsy; §=specimens harvested from stenoses during surgical revision. 
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scopy are needed to characterise and establish the 
origin of the hyperplastic intimal cells. Corroborating 
our findings, desmin positive cells are exclusively 22or 
mainly 23 present in the media in coronary vein bypass 
stenoses. 
Five other studies on the histopathology of peri- 
pheral vein bypass stenoses in humans have been 
published (Table 3) and a desmin stain was not used 
in any of these. In the original series of 21 specimens 
obtained uring autopsy or surgical revision Szilagyi 
eta[. 7 found intimal hyperplasia in four cases, fibrosis 
in seven and atherosclerotic changes in eight. The 
remaining two cases were non-diseased grafts. The 
median time interval from bypass grafting to tissue 
harvest was 12 months for lesions composed of intimal 
hyperplasia, 19 months for the fibrotic stenoses and 
59 months for the atherosclerotic changes. Using light 
microscopy Marin et al. 19 analysed 15 midgraft vein 
graft stenoses prior to and after balloon dilatation. 
These lesions consisted of intimal hyperplasia of vary- 
ing cellularity and fibrosis. No information about the 
age of the stenoses was given. In another study Marin 
and associates 2° examined biopsies of eight stenoses 
revised 3-13 months postoperatively and found 
spindle- or stellate-shaped cells dispersed within a 
dense fibrous tissue matrix. Thickened intimas of a 
similar appearance were identified in pre-bypass vein 
segments in six of these eight cases. In a recent pub- 
lication Sayers eta]. 21 described the histological struc- 
ture of two in situ and two reversed vein graft stenoses 
corrected surgically a median of 24 months post- 
operatively. Intimal hyperplasia composed of smooth 
muscle cells, with or without superadded thrombus, 
was the dominant finding. Sottiurai et al. ~8 studied 11 
distal anastomoses harvested from thrombosed vein 
grafts at reoperation or amputation. The time interval 
from graft insertion to revision ranged from 11-43 
months. In five of the graft segments there were no 
pathological findings, but in the other six, intimal 
hyperplasia was identified at the heel and toe of 
the anastomosis. Transmission electron microscopy 
revealed that the intima cells were smooth muscle 
cells, some of which showed evidence of degenerative 
changes whereas others were transformed into myo- 
fibroblasts, characterised by fewer myofilaments, large 
amounts of rough endoplasmatic reticulum and 
numerous Golgi complexes. These myofibroblasts are 
assumed to be involved in the synthesis of extracellular 
matrix and collagen fibres. 18'24 
In the present study lipid and calcification were 
identified in only one specimen, which originated from 
a proximal anastomosis lesion harvested 33 months 
postoperatively and therefore may represent pro- 
gression of the inflow atherosclerosis rather than being 
a true graft lesion. In accord with Szilagyi's 7 ob- 
servations atherosclerotic material and calcification 
are frequently found in older coronary vein bypass 
stenoses. 22It therefore seems likely that the initial 
cellular intimal hyperplasia gradually becomes more 
fibrotic and eventually undergoes atherosclerotic de- 
gradation, similar to the structural alterations oc- 
curring in arterial stenoses with time. 
In accordance with previous reports a°'25'26 we found 
that saphenous vein segments obtained prior to bypass 
grafting showed evidence of intimal hyperplasia of 
the exact same composition as graft stenoses. These 
pre-existing vein changes are assumed to adversely 
influence bypass patency, 2°possibly by forming a nidus 
for thrombosis and continued intimal hyperplasia. 27
Recently, however, the role of vein morphology in the 
development of graft stenoses has been questioned 2s 
and further prospective studies are necessary to clarify 
this issue. 
The histopathological changes after vascular injury 
have been extensively studied in vitro and in vivo. 
Endothelial denudation induces lymphocyte in- 
filtration, platelet aggregation and mural thrombus 
formation. Minor injuries are re-endothelialised within 
days by ingrowth of viable endothelial cells originating 
from the edges or from the adjacent in- or outflow 
artery. More extensive damage of the intima and me- 
dial cells leads to migration of smooth muscle cells 
from the media through disrupted elastic laminae to 
the intima, and results in subsequent proliferation in 
the intima. 15 Several growth factors including fibroblast 
factor (FGF), platelet derived growth factor (PDGF) 
and interleukin 1-~ released from the damaged intimal 
cells and from thrombocytes may stimulate this pro- 
cess.11,29, 30 
The histological features of vein bypass stenoses 
in humans closely resemble the structural changes 
induced by vascular injury and thus support he hypo- 
thesis of a causal relationship between intraoperative 
vein graft injury and postoperative development of 
stenoses. ~°'II'1s The traumatic events initiating the in- 
timal hyperplasia have not been identified. Though 
surgical preparation of the saphenous vein leads to 
morphological and functional endothelial injury, 16 a 
prospective study 31 failed to show any correlation 
between clamp sites, sidebranches or valve cusps and 
the postoperative of stenoses. Compliance mismatch 
or geometric deformations due to suture lines, 32 peri- 
anastomotic turbulence ~4 or altered haemodynamic 
conditions following arterialisation I° may be of patho- 
physiological significance. 
In conclusion, vein graft stenoses are characterised 
by intimal hyperplasia interspersed with areas of fib- 
rosis. Further in vivo studies are needed to characterise 
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the nature of the intima cells and to elucidate the 
pathogenesis of vein graft stenoses in humans. 
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